The NOT logic CAR was initially conceived by fusing the intracellular domain of PD1 or CTLA4 with a targeting domain recognizing antigens expressed on healthy tissues, thus allowing the primary tumor-targeting CAR to selectively kill tumor cells (185). Here, CTLA4 is linked to neoplasm.